Abstract
Background: In an attempt to reduce the length of conventional MDR TB regimen for 18months or more WHO updated its treatment guidelines in May 2016and included a recommendation on the use of Standardised Shorter MDR TB regimen with seven drugs and a treatment duration of 9to 12 months. The study explored the experience of the programmatic management of tuberculosis on a shorter injectable containing MDRTB regimen in a tertiary care centre in western Uttar Pradesh, India. Materials and Methods: Retrospective analysis of the data in a tertiary care centre in western up was carried out. The following attributes were included in outcome analysis: 1) Cured, 2) Treatment completed, 3) Treatment failure, Treatment regimen changed, 4) Died, 5) Lost to follow up. Results: Out of 87cases 43 are Male and 44 are female. Out Of the 87cases, 15 Cases were Cured ,57 Cases Treatment Completed, in 7 Patient treatment is changed or treatment is failed, 7 patients died in which 3 patients are female and 4 patients are male and 1 lost to follow up.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
